Semaglutide is gaining traction as a novel treatment for type 2 diabetes. This synthetic glucagon-like peptide-1 (GLP-1) receptor agonist functions through stimulating the pancreas to release more insulin and https://lucsips678167.howeweb.com/36362864/grasping-semaglutide-a-comprehensive-guide